Israel Biotech Fund

company

About

Israel Biotech Fund invests exclusively in biotech companies developing drugs at or near clinical stages.

  • 1 - 10

Highlights

Details

Industries
Biotechnology,Financial Services,Medical
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
MVC

Israel Biotech Fund – Building the future of Israeli Biotech
Israel Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies.
Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages.
Our partners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals.
Our key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support.
We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance.
We provide our portfolio companies with the necessary resources for long-term sustainable growth. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Israel’s Biotech industry which increases investment opportunities.
The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.

Investments

Number of Investments
Number of Lead Investments
1
0
Israel Biotech Fund has made 1 investments. Their most recent investment was on May 13, 2021, when Splisense raised $28.50M.
Date Company Name
Round Money Raised Industry Lead Investor
May 13, 2021 Splisense
Series B $28.50M Biotechnology